Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit–The EU Regulator's Perspective

by Maria E. Sheean, Frauke Naumann-Winter, Frauke Naumann-Winter, Giuseppe Capovilla, Giuseppe Capovilla, Giuseppe Capovilla, Maria Elisabeth Kalland, Maria Elisabeth Kalland, Eva Malikova, Eva Malikova, Eva Malikova, Segundo Mariz, Darius Matusevicius, Darius Matusevicius, Robert Nistico, Robert Nistico, Brigitte Schwarzer-Daum, Brigitte Schwarzer-Daum, Stelios Tsigkos, Kyriaki Tzogani, Kristina Larsson, Armando Magrelli, Armando Magrelli, Violeta Stoyanova-Beninska, Violeta Stoyanova-Beninska
Published 2021-08-01